Progress in treatment of multiple myelomain year 2012
Journal Title: OncoReview - Year 2013, Vol 3, Issue 2
Abstract
Authors and Affiliations
Artur Jurczyszyn, Anna Engel
Keywords
Related Articles
- EP ID EP53212
- DOI -
- Views 235
- Downloads 0
Everolimus – effectively reverses acquired resistance on endocrine therapy of patients with advanced breast cancer. A case report
Breast cancer is the most common malignancy among women in Poland. Endocrine therapy is the first line of treatment in hormone-receptor-positive advanced breast cancer. Progression during endocrine therapy is unavoidable...
Ewerolimus w codziennej praktyce klinicznej. Omówienie niemieckiego nieinterwencyjnego badania ewerolimusu w terapii przerzutowego raka nerki po niepowodzeniu leczenia inhibitorami kinaz tyrozynowych
Leczenie przerzutowego raka nerki ewerolimusem po niepowodzeniu terapii anty-VEGF jest obecnie standardem. Badacze niemieccy zebrali dane z 79 ośrodków w celu oceny bezpieczeństwa i skuteczności leku. Otrzymane wyniki by...
Application of echocardiography in oncology – practical remarks
The paper presents the contemporary use of echocardiography in diagnosis of primary and metastatic tumors of the heart as well as in assessment of cardiovascular risk related to medical and interventional oncological the...
„D-dimerosis” among the patients with the cancer it is always needed to be treated?
The risk of thromboembolic disease increases in malignant tumors. D-dimer is a product of fibrin degradation. Its concentration rises in neoplasms, but also in another diseases characterized by activation of clotting and...
Coronary angioplasty and aortic valve replecement in two patients with multiple myeloma - case reports
Multiple myeloma is a hematological disorder characterized by a clonal proliferation of atypical plasma cells, which produce a monoclonal immunoglobulin. The annual incidence rate in Europe is about 4.5/100 000 persons,...